PubMedopen access
Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude
humans, female, breast neoplasms, erb-b2 receptor tyrosine kinases, middle aged, retrospective studies
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 309485
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.